Skip to main content

Advertisement

Log in

GSK-3β Gene Expression in Human Postmortem Brain: Regional Distribution, Effects of Age and Suicide

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Glycogen synthase kinase (GSK-3β) has been implicated in the pathophysiology of mood disorders and schizophrenia. To examine its role in suicide, we determined GSK-3β messenger RNA (mRNA) in human postmortem brain from suicide and normal control subjects using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) technique. We found that GSK-3β mRNA was highly abundant in almost all of the 12 brain areas we studied. We also found a significant age effect on GSK-3β and that GSK-3β mRNA level were significantly higher in prefrontal cortex (PFC) and hippocampus of teenage normal controls compared with adult normal controls and was significantly decreased in PFC of teenage suicide but not adult suicide victims compared with respective normal control subjects. The decrease observed in the mRNA levels in teenage suicide but not in adult suicide victims may represent a neurodevelopmentally associated decrease and may be important in the pathophysiology of teenage suicide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Moscicki EK, O’Carroll P, Rae DS, Locke BZ, Roy A, Regier DA (1988) Suicide attempts in the Epidemiologic Catchment Area Study. Yale J Biol Med 61:259–268

    PubMed  CAS  Google Scholar 

  2. Minino AM, Smith BL (2001) Deaths: preliminary data for 2000. Natl Vital Stat Rep 49:1–40

    CAS  Google Scholar 

  3. Botsis AF, Soldatos CR, Stefanis CN (1997) Suicide: biopsychological approaches. Elsevier, Amsterdam

    Google Scholar 

  4. Harris EC, Barraclough B (1997) Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170:205–228

    Article  PubMed  CAS  Google Scholar 

  5. Kessler RC, McGonagle KA, Zhao S et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19

    PubMed  CAS  Google Scholar 

  6. Lönqvist J (2000) Psychiatric aspects of suicidal behavior: Depression. In: von Heeringen K, Hawton K (eds) The International Handbook of Suicide and Attempted Suicide. Wiley, Chichester, UK, pp 107–120

  7. Moscicki E (1977) Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am 20:499–517

    Article  Google Scholar 

  8. Regier DA, Farmer ME, Rae DS et al (1993) One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatr Scand 88:35–47

    Article  PubMed  CAS  Google Scholar 

  9. Gross-Isseroff R, Biegon A, Voet H, Weizman A (1998) The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci Biobehav Rev 22:653–661

    Article  PubMed  CAS  Google Scholar 

  10. Pandey GN, Dwivedi Y, Rizavi HS et al (2002) Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159:419–429

    Article  PubMed  Google Scholar 

  11. Pacheco MA, Stockmeier C, Meltzer HY, Overholser JC, Dilley GE, Jope RS (1996) Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res 723:37–45

    Article  PubMed  CAS  Google Scholar 

  12. Dwivedi Y, Rao JS, Rizavi HS et al (2003) Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:273–282

    Article  PubMed  CAS  Google Scholar 

  13. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2002) mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology 27:499–517

    PubMed  CAS  Google Scholar 

  14. Jope RS, Song L, Grimes CA et al (1998) Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence. J Neurochem 70:763–771

    Article  PubMed  CAS  Google Scholar 

  15. Dwivedi Y, Rizavi HS, Shukla PK et al (2004) Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 55:234–243

    Article  PubMed  CAS  Google Scholar 

  16. Pandey GN, Dwivedi Y, Pandey SC, Conley RR, Roberts RC, Tamminga CA (1997) Protein kinase C in the postmortem brain of teenage suicide victims. Neurosci Lett 228:111–114

    Article  PubMed  CAS  Google Scholar 

  17. Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Conley RR (2004) Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Arch Gen Psychiatry 61:685–693

    Article  PubMed  CAS  Google Scholar 

  18. Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391–426

    Article  PubMed  CAS  Google Scholar 

  19. Dale TC (1998) Signal transduction by the Wnt family of ligands. Biochem J 329(Pt 2):209–223

    PubMed  CAS  Google Scholar 

  20. Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59–88

    Article  PubMed  CAS  Google Scholar 

  21. Patapoutian A, Reichardt LF (2000) Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol 10:392–399

    Article  PubMed  CAS  Google Scholar 

  22. Behrens J, Jerchow BA, Wurtele M et al (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596–599

    Article  PubMed  CAS  Google Scholar 

  23. Moon RT, Brown JD, Torres M (1997) WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13:157–162

    Article  PubMed  CAS  Google Scholar 

  24. Shaw PC, Davies AF, Lau KF et al (1998) Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes. Genome 41:720–727

    Article  PubMed  CAS  Google Scholar 

  25. Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9:2431–2438

    PubMed  CAS  Google Scholar 

  26. Beasley C, Cotter D, Khan N et al (2001) Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci Lett 302:117–120

    Article  PubMed  CAS  Google Scholar 

  27. Cotter D, Kerwin R, al-Sarraji S et al (1998) Abnormalities of Wnt signalling in schizophrenia—evidence for neurodevelopmental abnormality. Neuroreport 9:1379–1383

    Article  PubMed  CAS  Google Scholar 

  28. Kozlovsky N, Belmaker RH, Agam G (2000) Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 157:831–833

    Article  PubMed  CAS  Google Scholar 

  29. Nadri C, Dean B, Scarr E, Agam G (2004) GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients. Schizophr Res 71:377–382

    Article  PubMed  Google Scholar 

  30. Lesort M, Greendorfer A, Stockmeier C, Johnson GV, Jope RS (1999) Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain. J Neural Transm 106:1217–1222

    Article  PubMed  CAS  Google Scholar 

  31. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455–8459

    Article  PubMed  CAS  Google Scholar 

  32. Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664–1668

    Article  PubMed  CAS  Google Scholar 

  33. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G (1999) Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 60(Suppl 2):27–39 discussion 40-1, 113-6

    PubMed  Google Scholar 

  34. Salzman S, E.J., Clayton P, Winokur G (1983) Diagnostic Evaluation After Death (DEAD). National Institute of Mental Health Neuroscience Research Branch, Rockville

  35. Spitzer RL, Williams JB, Gibbon M, First MB (1992) The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624–629

    PubMed  CAS  Google Scholar 

  36. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60:804–815

    Article  PubMed  CAS  Google Scholar 

  37. Leroy K, Brion JP (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16:279–293

    Article  PubMed  CAS  Google Scholar 

  38. Kozlovsky N, Nadri C, Agam G (2005) Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult. Eur Neuropsychopharmacol 15:1–11

    Article  PubMed  CAS  Google Scholar 

  39. Nadri C, Lipska BK, Kozlovsky N, Weinberger DR, Belmaker RH, Agam G (2003) Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia. Brain Res Dev Brain Res 141:33–37

    Article  PubMed  CAS  Google Scholar 

  40. Fradkin LG, Garriga G, Salinas PC, Thomas JB, Yu X, Zou Y (2005) Wnt signaling in neural circuit development. J Neurosci 25:10376–10378

    Article  PubMed  CAS  Google Scholar 

  41. Ciani L, Salinas PC (2005) WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat Rev Neurosci 6:351–362

    Article  PubMed  CAS  Google Scholar 

  42. Bijur GN, Jope RS (2001) Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem 276:37436–37442

    Article  PubMed  CAS  Google Scholar 

  43. Pap M, Cooper GM (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 273:19929–19932

    Article  PubMed  CAS  Google Scholar 

  44. Mai L, Jope RS, Li X (2002) BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 82:75–83

    Article  PubMed  CAS  Google Scholar 

  45. Manji HK, Moore GJ, Chen G (2000) Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 61(Suppl 9):82–96

    PubMed  CAS  Google Scholar 

  46. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55:781–784

    Article  PubMed  CAS  Google Scholar 

  47. Beasley C, Cotter D, Everall I (2002) An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder. Schizophr Res 58:63–67

    Article  PubMed  Google Scholar 

  48. Karege F, Perroud N, Burkhardt S et al (2007) Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61:240–245

    Article  PubMed  CAS  Google Scholar 

  49. Jope RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24:441–443

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant RO1 MH 48153 (Dr. Pandey) and KO1 MH 01836 and RO1 MH 068777 (Dr. Dwivedi) and R01 MH60744 (Dr. Roberts) from the National Institute of Mental Health, Rockville, MD; and by a Distinguished Investigator grant (Dr. Pandey) and a Standard Research grant from the American Foundation for Suicide Prevention, New York, NY (Dr. Dwivedi) and a grant from NARSAD (Dr. Dwivedi). We thank Barbara Brown, B.S., and Miljana Petkovic, B.S., for their help in organizing the brain tissue. We also thank the members of the Maryland Brain Collection at the Maryland Psychiatric Research Center for their efforts, particularly in family interviews and dissection. We are grateful for the cooperation of Office of the Chief Medical Examiner.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ghanshyam N. Pandey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pandey, G.N., Dwivedi, Y., Rizavi, H.S. et al. GSK-3β Gene Expression in Human Postmortem Brain: Regional Distribution, Effects of Age and Suicide. Neurochem Res 34, 274–285 (2009). https://doi.org/10.1007/s11064-008-9770-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-008-9770-1

Keywords

Navigation